| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |